AllosteRx Capital Management (Canada) Inc.
Montreal, QCEarly-stage biotechnology venture capital focused on the Quebec life sciences ecosystem.
19 venture capital firms in Montreal with active theses in HealthTech / Life Sciences. Browse thesis focus, check sizes, and recent deals below.
Early-stage biotechnology venture capital focused on the Quebec life sciences ecosystem.
Early-stage life science venture capital fund and major supporter of Quebec's academic innovation, focusing on pre-seed and seed investments to create startups around groundbreaking technologies.
Capital catalyst for precision medicine and next-generation medical devices at point of value acceleration.
Focus on technology companies with validated product-market fit ready to accelerate growth. Staged strategy with discovery checks, building conviction by tracking execution.
Pre-seed/seed-stage venture fund launched in close partnership with Centech, entirely dedicated to investing in Centech and Quebec's most promising deeptech startups.
Canada's second-largest pension fund and one of the world's largest institutional investors. Active direct investor and LP in the Canadian VC ecosystem.
Venture capital firm investing in high-quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and the US.
Early-stage digital health venture fund investing in Canada and the US.
Invest in innovative private companies developing breakthrough therapies. Join last or second-to-last private financing round.
Quebec's largest labour-sponsored venture capital fund with $20B+ in net assets. Provides venture and development capital to thousands of Quebec businesses from startup to expansion.
Grows an innovation ecosystem transforming markets and propelling technology companies toward market leadership.
Focus on software companies and AI driving positive impact on global scale. Three strategies: Discovery, Venture, Growth.
National Bank's technology banking group offering venture lending, growth and M&A financing for tech companies for over 20 years. Acquired SVB's ~C$1B Canadian loan portfolio in 2023. Also operates NA
Led by experienced operators with strong angel and institutional VC track records; founders-first philosophy with commitment to diversity, co-investing with angel investors and seed funds across Canad
Private equity fund exclusively focused on high-growth opportunities in the healthcare field.
Emerging life science companies developing innovative medical treatments based on disruptive technologies.
Building global healthcare leaders from locally disruptive technologies. MedTech, Biotech, AI in Health.
Canada's largest innovation-focused fund-of-funds investor. Backed by CDPQ, Fondaction, and government programs, with over $2.5B committed to 5 specialized VC fund-of-funds.
Montreal-based PE firm partnering with management teams of mid-market businesses in Quebec and Canada to drive growth.